Suven Life Sciences Limited

This study is testing whether an experimental drug called masupirdine can safely reduce agitation in people with Alzheimer's dementia. About 375 participants will take either the drug or a placebo pill daily for 12 weeks. Researchers will measure changes in aggressive behaviors, …

This is the first study to test a new oral drug called SUVN-I6107 in people. It aims to check if the drug is safe, how the body processes it, and if it affects brain activity in healthy volunteers. The study involves giving single and multiple doses to up to 64 healthy adults and…